| Cover | Jan. 07, 2025 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Jan. 07, 2025 |
| Entity File Number | 001-41952 |
| Entity Registrant Name | TELOMIR PHARMACEUTICALS, INC. |
| Entity Central Index Key | 0001971532 |
| Entity Tax Identification Number | 87-2606031 |
| Entity Incorporation, State or Country Code | FL |
| Entity Address, Address Line One | 100 SE 2nd St |
| Entity Address, Address Line Two | Suite 2000, #1009 |
| Entity Address, City or Town | Miami |
| Entity Address, State or Province | FL |
| City Area Code | (786) |
| Local Phone Number | 396-6723 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, no par value |
| Trading Symbol | TELO |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
